Bacteria and viruses and clinical outcomes of asthma‐bronchiectasis overlap syndrome: A cohort study

Author:

Zhang Xiao‐xian1,He Jia‐hui1,Pan Cui‐xia1,He Zhen‐feng1,Li Hui‐min1,Lin Zhen‐hong1,Zhang Xiao‐fen1,Cen Lai‐jian1,Zhang Ri‐lan1,Shi Ming‐xin1,Guan Wei‐jie1ORCID

Affiliation:

1. State Key Laboratory of Respiratory Disease National Clinical Research Center for Respiratory Disease Guangzhou Institute for Respiratory Health The First Affiliated Hospital of Guangzhou Medical University Guangzhou Guangdong China

Abstract

AbstractBackgroundDespite the high prevalence of co‐existing bronchiectasis and asthma (asthma‐bronchiectasis overlap syndrome [ABOS]), little is known regarding the dominant pathogens and clinical correlates.ObjectiveTo investigate the bacteria and viruses which differentially dominate in ABOS (including its subtypes) compared with bronchiectasis alone, and determine their relevance with bronchiectasis severity and exacerbations.MethodsThis was a prospective observational cohort study conducted between March 2017 and August 2023. We included 81 patients with ABOS and 107 patients with bronchiectasis alone. At steady‐state baseline, patients underwent comprehensive assessments and sputum collection for bacterial culture and viral detection (quantitative polymerase‐chain‐reaction). Patients were followed‐up to record exacerbation and spirometry.ResultsPatients with ABOS had significantly higher symptom burden and exacerbation frequency than those with bronchiectasis alone. Despite similar pathogen spectrum, the rate of bacteria–virus co‐detection increased less substantially at acute exacerbations (AE) onset than at steady‐state compared with bronchiectasis alone. Pathogenic bacteria (particularly Pseudomonas aeruginosa) were detected fairly common (exceeding 50%) in ABOS and were associated with greater severity of bronchiectasis when stable and conferred greater exacerbation risks at follow‐up. Viral but not bacterial compositions changed substantially at AE onset compared with clinical stability. Higher blood eosinophil count, moderate‐to‐severe bronchiectasis and non‐atopy were associated with higher odds of bacterial, but not viral, detection (all p < 0.05).ConclusionDetection of bacteria or virus is associated with bronchiectasis severity or clinical outcomes in ABOS. This highlights the importance of integrating sputum microbial assessment for ascertaining the dominant pathophysiology (atopy vs. infection) and longitudinal trajectory prediction in ABOS.

Publisher

Wiley

Subject

Immunology and Allergy,Immunology,Pulmonary and Respiratory Medicine

Reference35 articles.

1. Global Initiative for Asthma.Global Strategy for Asthma Management and Prevention;2023. Accessed October 07 2022.www.ginasthma.org

2. Guidelines for bronchial asthma prevent and management (2020 edition);Asthma group of Chinese Throacic Society;Chin J Tubere Respir Dis,2020

3. Pulmonary infection assembly, Chinese thoracic society. expert consensus on the diagnosis and treatment of adult bronchiectasis in China;Bronchiectasis Expert Consensus Writing Group;Chin J Tubere Respir Dis,2021

4. Does asthma-bronchiectasis overlap syndrome (ABOS) really exist?

5. Analysis of bronchiectasis in hospitalized asthmatic patients: 10‐year experience of a single center;Xie H;Zhong Hua Yi Xue Za Zhi,2019

全球学者库

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"全球学者库"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前全球学者库共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2023 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3